Dr. Bulliard is a trained epidemiologist (PhD), scientific Director of the Neuchâtel-Jura Swiss cancer registry, and a senior research and teaching fellow at the Centre for Primary Care and Public Health (Unisanté), University of Lausanne, where he leads the Sector Epidemiology and Public Health Data Science. Involved in cancer epidemiology and prevention for over 25 years, his expertise includes evaluation, modelling and implementation of cancer screening programmes (breast, colon and lung). Dr Bulliard has been actively involved within the ICSN since 1999, with participation to several ICSN scientific publications and working groups, and former member of its steering Committee.

Dr Christine Campbell is a Reader at the Usher Institute at the University of Edinburgh. She leads a programme of research into socio-demographic and ethnic disparities in cancer outcomes, the role of primary care in screening provision and symptomatic diagnosis, and implementation of cervical screening in low resource settings.

Dr. Róisín McCarthy is a Research Officer at the National Screening Service (NSS), Health Service Executive, Ireland. Róisin has a background in public health and clinical research. She is part of the Programme Evaluation Unit team at the NSS which is involved in retrieving, validating and collating data for the evaluation of the four National Screening Programmes - Breast, Bowel, Cervical and Diabetic Retina Screening. Róisin contributes to annual reports, quality assurance meetings and research projects within her role.

Andrew Prentice is a Public Health Specialist who has worked in many health fields including HIV, malnutrition, mental health and more recently Bowel Cancer Screening. He has worked extensively in Africa and the Middle East, for the WHO and many of the International NGOs and currently heads up the Health Promotion Team at St Mark’s Hospital with a focus on Bowel Cancer Screening. Andrew works across both primary care and community settings with the aim of raising awareness of bowel cancer, the importance of screening and early detection and to reduce inequalities in screening uptake and diagnostic services

Navkiran K. Shokar, M.D., MPH, is Chair of the Department of Population Health, Associate Dean for Community Affairs at Dell Medical School at The University of Texas at Austin, and Program Lead of the Cancer Prevention and Control Research Program at Livestrong Cancer Institutes. In more than 20 years in academic medicine, Shokar has worked as a clinician, educator and clinical researcher. Her research interests include interventions in cancer prevention and control, shared decision-making, and community-based research to address cancer health disparities among vulnerable and underserved populations.